Artemisia Scientific Steering Group firstname.lastname@example.org
The Artemisia Scientific Steering Group seek to promote access to Artemisia as a mean against malaria by:
- Supporting the scientific research, both agronomic and medical, necessary to convince WHO to lift its ban on the use and marketing of the plant so as to encourage all official bodies, including specialized United Nations bodies involved in agriculture, health, education and human rights, to contribute to accelerating the controlled dissemination of these Artemisia;
- The organization of symposiums in Africa on Artemisia effective against malaria and other tropical infectious disease. These conferences:
o Treat the benefits of plants as repellents against malaria vectors and other insect-borne diseases, as prophylactics and cures against tropical infectious diseases;
o Bring together African national official authorities and WHO and other relevant United Nations bodies, African and international researchers, plant practitioners;
The Steering Group is composed of African and international biologists, pharmacists, doctors, chemists, economists, agronomists and practitioners of Artemisia concerned to contribute to the development of these plants in Africa.
The Steering Group acts at the African national and regional levels as well as at the international level.
Researchers on the Steering Group will regularly share their research results and field experiences, including cultural practices and dosages applied.
It is directed by Researcher Rosine Désirée Chougouo Kengne of the University of Mountains of Cameroon.
Context of the creation of this Group: Participants at the IDAY-International General Assembly in Conakry in March 2019 propose the creation of a Pan-African Scientific Steering Group to accelerate the dissemination of Artemisia annua and afra in Africa in accordance with WHO standards.
Indeed, considering that:
- Malaria still kills more than 400,000 people a year worldwide, including 366,000 African children, or 1,000 children a day;
- The World Health Organization (WHO) reports on malaria in 2017 and 2018 show that:
o since 2016, progress against malaria has been stagnant
o In Africa, the incidence rate is 219 per 1,000 people (world average: 59/1000)
o The most affected countries are experiencing an increase in incidence (in Africa Nigeria, DRC, Mozambique, Uganda and India)
o Resistance to pesticides used on mosquito nets and to one or more of the two components of Artemisinine-based Combination Therapy (ACT) has emerged around the world
o ACTs are frequently used against diseases other than malaria, thus unnecessarily accelerating the emergence of resistance
- 50% of ACTs distributed in trade in Africa are counterfeit;
- The shelf-life of ACTs under tropical climatic conditions is limited;
- The official means used (ACT, impregnated mosquito nets, indoor pesticides, early diagnosis, treatment for pregnant women) are expensive, with the consequence that they are not accessible to all, also taking into account the limitations of the amounts of international funding available;
- There are serious doubts about the sustainability of the official approach, as Richard Horton already mentioned in a 2011 article and as confirmed by the resurgence of malaria in countries such as India and Mozambique where malaria had been virtually eradicated;
- Nearly 70% of the African population uses community medicine;
- The enormous potential of Artemisia annua and afra as established by the history of the plant in China, the countless field observations in Africa and elsewhere, the extensive research both in vitro and in vivo on the plant, and in particular those demonstrating a lower sensitivity of plants to the creation of resistance;
- The diagnosis by many African authorities that they would not succeed in achieving the Sustainable Development Goal (SDO) affected by malaria (SDOs 3.1, 3.2 and 3.3) without the intervention of new means of control;
- Malaria has real impacts on the social and economic development of affected countries.
- 13 Members
- 8 Topics, Last Post:
- Started on
Group Email Addresses
- This is a subgroup of dgroups.
- All members can post to the group.
- Posts to this group require approval from the moderators.
- Messages are set to reply to group.
- Subscriptions to this group require approval from the moderators.
- Archive is visible to anyone.
- Wiki is visible to members only.
- Members can edit their messages.
Top Hashtags [See All]No used hashtags.